STATEMENT ON SENATE 340B BIPARTISAN WORKING GROUP DISCUSSION DRAFT
WASHINGTON, D.C.— Today, three Republican and three Democratic senators issued a 340B discussion draft of a bill aimed at making changes to the 340B drug pricing program and requested feedback from stakeholders on numerous provisions in the bill. 340B Health welcomes the opportunity to submit comments to the senators on behalf of the more than 1,500 hospitals and health systems we represent. The following statement is attributed to Maureen Testoni, president and CEO of 340B Health:
“340B Health appreciates the leadership of Sens. John Thune (R-S.D.), Debbie Stabenow (D-Mich.), Shelley Moore Capito (R-W.V.), Tammy Baldwin (D-Wis.), Jerry Moran (R-Kan.), and Benjamin Cardin (D-Md.) on 340B issues, especially on the devastating contract pharmacy restrictions by drug manufacturers—potentially impacting $8.4 billion in 340B savings per year. We look forward to reviewing the materials in more detail and working with our members to submit comments to ensure that 340B continues to support safety-net providers in maintaining, improving, and expanding access for low income and underserved populations.”
“340B hospitals play a vital role in the health care safety net, bridging critical gaps in health care access. They deliver 77% of Medicaid hospital care and 67% of the nation’s uncompensated and unreimbursed care. They use 340B savings to provide comprehensive, specialized services to patients in need and extend care to rural communities that otherwise would lack access, all without relying on taxpayer funding to do so.”
Contact: Jon Tilton at jon.tilton@340bhealth.org or 202-536-2285